Protocol Review Service
Optimize your clinical trials with an expert review of your protocol by the Iowa Diabetes Research Team.
- 17+ Years as a Research Site
- 230+ Clinical Research Trials
- Multidisciplinary Team of Experts
- Comprehensive Protocol Evaluation
- 3-4 Week Standard Turnaround Time
Purpose
The Iowa Diabetes Research Protocol Review Service supports Sponsors by providing a thorough and detailed review of clinical trial protocols. As a research center with over 17 years of experience in more than 230 diabetes, obesity, and related conditions trials, we understand the complexities involved in this process.
Many clinical trials require amendments to address clinical or operational issues, correct errors, or improve recruitment. The multi-disciplinary team at Iowa Diabetes aims to increase trial success by ensuring protocols are both feasible and effective. This service helps companies prepare their trials for success from the start.
Our goal is to optimize clinical trial protocols, reduce amendments, and prevent unnecessary and costly delays throughout the entirety of your clinical study.Our Expert Team
This service includes a comprehensive evaluation of clinical trial protocols conducted over a period of 3-4 weeks by a multidisciplinary team of experts
Principal Investigator
Medical expertise, oversight of clinical safety, and review of protocol design by an experienced physician
Director of Innovation and Growth
Feasibility of study design, protocol logistics & alignment
Sub-Investigator
Evaluation of trial design from an investigator’s perspective
Clinical Research Coordinator
Review of trial conduct, Schedule of Activities, and protocol procedures
Patient Care Navigator
Assessment of participant recruitment strategies, challenges, and opportunities
Start-Up Specialist
Review of the start-up feasibility and site initiation considerations
Key Areas of Focus
Trial Design
Evaluating scientific rigor, feasibility, and alignment with clinical objectives.
Recruitment Strategy
Identifying potential challenges and recommending solutions for smoother enrollment.
Eligibility Criteria
Assessing for realistic and optimal participant eligibility.
Schedule of Assessments
Reviewing the timing and frequency of procedures to ensure alignment with study objectives.
Risk Management
Identifying risks and recommending mitigation strategies.
Overall Improvement Suggestions
Providing actionable recommendations for a more streamlined and efficient trial.
Client Testimonials
See what our clients have to say about our Protocol Review Service
“Our team greatly appreciated the time, effort, and thoughtful analysis that Iowa Diabetes Research dedicated to our protocol review. The structured feedback and collaborative approach brought valuable insights from multiple perspectives—clinical, operational, and recruitment. Their review helped us refine our protocol and proactively address potential challenges. We would not hesitate to work with Iowa Diabetes Research again.”
Biotech Company
“The support we received from Iowa Diabetes Research during our protocol review was exceptional. Their team delivered fast, high-quality, and thoughtful feedback that truly strengthened our trial design. The communication was clear, timely, and well-coordinated across all stages of the review process. We came away with a more refined protocol and increased confidence in our trial’s feasibility and success.”
Biotech Company
Service Options
Choose the package that best fits your needs. A detailed fee structure will be provided upon initial inquiry.
Basic Review Package
For standard protocol reviews
Contact for pricing
- Comprehensive protocol review
- 3-4 Week turnaround time
- Detailed written report
- One follow-up consultation
Expedited Review Package
For time-sensitive protocols
Contact for pricing
- Priority comprehensive review
- Accelerated 2-3 week turnaround
- Detailed written report
- Priority access to team members
Confidentiality
Iowa Diabetes Research will maintain strict confidentiality regarding all submitted materials, including the protocol, sponsor information, and any other proprietary data shared during the review process.
A Confidential-Disclosure Agreement (CDA) may be executed between Iowa Diabetes Research and the sponsor to formalize confidentiality expectations.
